Ophirex, is developing a first in class drug that will help the 500,000 people who die or suffer amputations each year from venomous snakebite. 70% of those who die never even make it to the hospital for treatment. Because Ophirex's drug will be available in an oral formulation, all that will change. Our drug is a small molecule inhibitor that